Abilify MyCite

Otsuka America Pharmaceutical, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 16, 2023
Approval ID: e8787c3f-5e41-42d1-8091-44b56346620f
Products: 6 registered
Version: 14

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002

Quick Stats

Total Products6

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.